CD8A and neoplasm: Although no direct quantification of CTLA-4 mRNA or protein levels in immune cells was performed in this study, the observed immunological effects—such as increased tumor-infiltrating CD8+ T cells, enhanced IFN-γ secretion, and stronger CTL activity in the siRNA-treated groups—indirectly confirm the functional elimination of CTLA-4.